Immunofluorescence Assay Market

The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years. However, quality concerns over antibodies are the major challenge in this market.

The immunofluorescence assays market is fragmented, with the presence of a large number of players offering a variety of products. The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Abcam plc (UK), Bio-Rad Laboratories, Inc. (US), PerkinElmer Inc. (US), Merck KGaA (Germany), Werfen Company (Spain), Cell Signaling Technology, Inc. (US), MEDIPAN GmbH (Germany), Sino Biological, Inc. (China), Danaher Corporation (US), Maravai LifeSciences (US), Enzo Biochem, Inc. (US), Becton, Dickinson and Company (US), Olympus Corporation (Japan), Nikon Corporation (Japan), Bruker Corporation (US), Agilent Technologies (US), Zyagen, Inc. (US), Cellabs (Australia), J. Mitra & Co. Pvt. Ltd. (India), Abnova Corporation (Taiwan), EpiGentek Group (US), Elabscience, Inc. (US), AESKU GROUP GmbH (Germany), and MaxVision Biosciences Inc. (Canada).

To know about the assumptions considered for the study download the pdf brochure

THERMO FISHER SCIENTIFIC (US)

Thermo Fisher is a leading player in the immunofluorescence assays market due to its extensive portfolio of primary antibodies, secondary antibodies, reagents, and instruments. The company offers customers a complete range of analytical instruments as well as laboratory equipment, consumables, and reagents. The company also has a strong geographic footprint serving pharmaceutical and biotechnology companies, hospitals and clinical diagnostic laboratories, universities, research institutes, and government agencies. The company pursues the strategy of acquisitions. In 2018, the company acquired BD, which helped it to broaden its Life Sciences Solutions’ portfolio. The company aims to expand its customer base in the emerging and high-growth regions.

DANAHER CORPORATION (US)

Danaher Corporation (US) accounted for the largest share of the immunofluorescence instruments market in 2019. The company offers microscopes through Leica Microsystems. To sustain its foothold and increase its share in the market, the company pursues inorganic growth strategies. In this regard, in 2017, Leica Biosystems partnered with the Kuwait Ministry of Health through its distributor, Technical Services Supplies Trading & Contracting Company, W.L.L., to provide Kuwait with Digital Pathology (DP) as its standard of care.

Related Reports:

Immunofluorescence Assay Market by Product (Reagent, Instruments, Antibodies, Kits, Consumables & Accessories), Type (Direct, Indirect), Disease (Infectious Disease, Other Diseases), End User (Contract Research Organizations) – Global Forecast to 2026

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]